• Home
  • Stock
  • Bliss GVS Pharma Fundamental Analysis
  • Bliss GVS Pharma Fundamental Analysis

Bliss GVS Pharma fundamental analysis

BLISSGVS

HealthcareSmall

162.19

1.46 (0.91%)
Last updated on 9 Dec, 2025 | 15:40 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Bliss GVS Pharma Fundamentals

P/E Ratio

15.51

P/B Ratio

1.5

Div. Yield

0.31

Sector P/E

35.5

Sector P/B

1.11

Sec. Div. Yield

0.57

Bliss GVS Pharma Fundamentals is currently trading with a P/E Ratio of 15.51, compared to the sector average of 35.5. Its P/B Ratio stands at 1.5, while the sector’s is 1.11. In terms of returns, the stock offers a Dividend Yield of 0.31%, which is than the sector’s 0.57%.

Bliss GVS Pharma Score Card

  • Price

    Attractive

  • Growth

    Average

  • Quality

    Good

  • Management

    Average

On its scorecard, Bliss GVS Pharma reflects: Price – Attractive, Growth – Average, Quality – Good, and Management – Average. Together, these indicators provide a structured view of the company’s fundamentals.